Naltrexone
Tips for starting medication in patients with opioid use disorder
SAN DIEGO — “Now more than ever,” physicians need to manage opioid use disorder with pharmacological treatment in the primary care setting, according to a speaker at the ACP Internal Medicine Meeting.
Disability linked to treatment rates for opioid use disorder
Among Medicaid beneficiaries with opioid use disorder, those with a disability were less likely to receive medication treatment and to adhere to treatment for 6 months, according to findings published in JAMA Network Open.
Those with opioid use disorder, polysubstance use less likely to initiate MOUD treatment
Individuals with opioid use disorder and polysubstance use were less likely to initiate treatment with buprenorphine and naltrexone than those without polysubstance use, according to a study published in JAMA Network Open.
VIDEO: Low-dose naltrexone shows promise in two patients with ‘complex’ refractory Crohn’s
Though further study is warranted, Leonard B. Weinstock, MD, FACP, adjunct professor at the Washington University School of Medicine, reported promising results of low-dose naltrexone use among two patients with Crohn’s disease.
Varenicline/naltrexone combination may improve drinking outcomes in heavy-drinking smokers
Concomitant targeting of smoking cessation and drinking reduction via pharmacotherapy appeared feasible, according to results of a randomized clinical trial published in American Journal of Psychiatry.
Naltrexone-bupropion more effective than placebo for methamphetamine use disorder
Responses to combination naltrexone-bupropion therapy among adults with methamphetamine use disorder were “low” but higher than responses to placebo, researchers reported.
Opioid use disorder medication, self-help groups rarely offered together
The National Institute on Drug Abuse states that self-help groups, “so long as they do not discourage participants from taking medications, can be particularly helpful during recovery” from opioid addiction.
Low-dose naltrexone safe, effective for neuropathic corneal pain
Clinical challenges in MDD patients with comorbid disorders
SAN DIEGO — In a video interview, W. Clay Jackson, MD, DipTh, clinical assistant professor of family medicine and psychiatry, University of Tennessee College of Medicine, talked about his presentation on the treatment of major depressive disorder with comorbid disorders.